MidAtlantic Neonatology Associates is a group of neonatologists, advanced neonatal practitioners and physician assistants dedicated to providing exemplary neonatal intensive care.

Quality Improvement

Preclinical research is essential to the elucidation of the mechanisms of disease.  Clinical and translational research take a vital step towards the patient.  However, Quality Improvement initiatives are where new information and evidence are brought to the bedside. While controlled clinical trials are the gold standard of proof, they are time-consuming and require years of study before patients can reap their benefits. Systematic quality improvement initiatives, on the other hand, allow clinicians to implement evidence-based innovations in a manner that allows us to assess their efficacy in the NICU.

Benchmarking is where the process begins. MANA clinicians monitor an array of clinical practices and outcomes in order to identify trends, positive and negative. In addition, we contribute data to the CDC and the Vermont Oxford Network (VON). The latter is a collaborative database that collects and analyzes an assortment of outcomes from very low birth weight infants (<1500 grams at birth) born all over the United States.

In conjunction with our colleagues in nursing and the allied health professions, MANA physicians are carrying out an assortment of rigorous QI initiatives.